ANVISA registration 80003610495ActiveANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP)
ANVISA Registration Number: 80003610495WERFEN MEDICAL LTDAINOVA DIAGNOSTICS , INC.Risk Class II
Device names
- Technical name
- ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP)
- Risk class
- Class II
PT: ANTI-PEPTÍDEO CITRULINADO CÍCLICO (ANTI-CCP)
Registration details
- Registration Number
- 80003610495
- Process Number
- 25351003037201573
- CNPJ
- 02004662000165
Company information
- Registration Holder
- WERFEN MEDICAL LTDA
- Manufacturer
- INOVA DIAGNOSTICS , INC.
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Apr 13, 2015
- Status
- Active
Official value: VIGENTE
About this record
Access comprehensive regulatory information for ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610495 and manufactured by INOVA DIAGNOSTICS , INC.. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.